HCW/IGRA cost effectiveness study hits medical news stands

The clinical news provider VerusMed are now running the story Interferon gamma release assays cost-effective alternatives to skin tests for diagnosing latent TB infection in new health care workers, study finds.

VerusMed ensures that

readers receive the most relevant therapeutic updates through a variety of media channels, including online, e-mail, fax, and RSS feeds

and is

a member of ConnectivHealth, a network of powerful health information brands that enables the delivery, distribution, and organization of important health information for physicians, health care professionals, hospitals, and schools through customized channels.

The news item has also been relayed by Siemens under Industry News